Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nitrogenase is a highly complex metalloenzyme system responsible for biological nitrogen fixation, the process of converting atmospheric dinitrogen (N2) into bioavailable ammonia (NH3) [3, 7, 13]. Found exclusively in prokaryotes such as symbiotic rhizobia in legume root nodules and free-living cyanobacteria, this enzyme plays a foundational role in the global nitrogen cycle [3, 11]. The functional complex typically comprises two metalloproteins: the dinitrogenase reductase (Fe protein) and the dinitrogenase (MoFe protein), which utilize specialized clusters like the iron-molybdenum cofactor (FeMoco) to facilitate the reduction of the exceptionally strong N-N triple bond [6, 10, 13]. The process is highly energy-intensive, requiring at least 16 ATP molecules per N2 reduced, and the enzyme is notoriously sensitive to oxygen, which causes irreversible inactivation of its metal clusters [4, 7, 18]. Although not a target for human therapeutic pharmaceuticals, nitrogenase is a principal target for agricultural biotechnology and synthetic biology research [1, 18]. Scientists aim to engineer these pathways into major cereal crops to reduce reliance on industrial Haber-Bosch fertilizers and decrease environmental nitrogen pollution [8, 14, 18].
Nitrogenase reduces dinitrogen (N2) to ammonia (NH3) via a sequence of electron and proton transfers. The process is driven by the Fe protein (reductase), which transfers electrons to the MoFe protein (dinitrogenase) in an ATP-dependent manner. Inhibitors like acetylene act as alternative substrates that compete for the active site, while molecules like carbon monoxide bind to the metal clusters to block substrate access. Oxygen acts as an irreversible inhibitor by destroying the iron-sulfur clusters essential for catalysis.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nitrogenase (N2ase).